Brokers name 3 ASX shares poised for 52% to 78% gains

A woman in a red dress holding up a red graph.

Picking a share that’s undervalued and enjoying the subsequent share price gains is what every investor is after, but it’s easier said than done.

I’ve had a look at the broker reports published this week and selected three that make a good case for potentially lucrative upside in the shares covered.

Let’s look at what they’re saying.

Seek Ltd (ASX: SEK)

Shares in the employment website and technology company have struggled over the past 12 months, shedding about 45% of their value over the period.

The analyst team at Jarden thinks the shares are oversold and bases this opinion on a “proprietary tracker” it has built to assess how Seek is faring.

In short, they think the company is well-positioned.

As they said:

We believe Seek can easily achieve its ‘low double digit’ yield growth guidance for FY26 … 2H26’s strong momentum gives us confidence that Seek can achieve its ‘high single digit’ % yield growth ambition in ANZ, with upside risk. Our proprietary tracker indicates that Seek has maintained its year-on-year pricing growth from 1H26 into 2H26.

Jarden notes that it believes the Australian labour market is past its peak, which will be a headwind for the company.

Jarden has a price target of $23.25 on Seek shares, down from $23.50, but still well above the current price of $13.07. If achieved, the price target would constitute a 77.8% gain.

Propel Funeral Partners Ltd (ASX: PFP)

Propel just announced three acquisitions in New Zealand, which will cost it $9.1 million and expand its network into regional markets.

Together, the companies being acquired generate about $4 million in revenue from more than 700 funerals annually and operate from four locations.

The company also gave guidance on its expected performance this year, saying revenue would be in the range of $225 to $230 million compared to last year’s $225.8 million, while EBITDA would be in the range of $54.5 to $56.5 million, compared to last year’s $56.2 million.

Macquarie downgraded its outlook for the company across the next three years, but still has a share price target of $5.50, well above current levels of $3.24. If achieved, the price target would constitute a 69.8% gain.

IperionX Ltd (ASX: IPX)

This company this week published a definitive feasibility study for its Titan critical minerals project in the US, which said the project could be developed over two stages for US$381.3 million.

The mine, which would produce titanium, zircon, and heavy rare earth concentrate, was expected to have a mine life of 14 years and to earn US$2.8 billion in EBITDA over that period.

Bell Potter, in a report issued this week, has a speculative buy rating on the shares, with a price target of $8.25 compared to the current price of $5.43.

If achieved, the price target would constitute a 51.9% return.

Bell Potter said the company now had the opportunity to forge ahead with funding and partnership discussions.

The post Brokers name 3 ASX shares poised for 52% to 78% gains appeared first on The Motley Fool Australia.

Should you invest $1,000 in Seek right now?

Before you buy Seek shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Seek wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.